• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

KHA-CARI Guideline: use of iron in chronic kidney disease patients.

作者信息

Macginley Rob, Walker Rowan, Irving Michelle

机构信息

Deakin University Medical School, Geelong, Victoria, Australia.

出版信息

Nephrology (Carlton). 2013 Dec;18(12):747-9. doi: 10.1111/nep.12139.

DOI:10.1111/nep.12139
PMID:23879376
Abstract
摘要

相似文献

1
KHA-CARI Guideline: use of iron in chronic kidney disease patients.KHA-CARI指南：慢性肾脏病患者铁剂的使用
Nephrology (Carlton). 2013 Dec;18(12):747-9. doi: 10.1111/nep.12139.
2
Chronic kidney disease, anemia, and epoetin.慢性肾病、贫血与促红细胞生成素
N Engl J Med. 2007 Mar 1;356(9):956; author reply 958-9. doi: 10.1056/NEJMc063535.
3
Darbepoetin alfa and chronic kidney disease.达贝泊汀α与慢性肾脏病
N Engl J Med. 2010 Feb 18;362(7):654-5; author reply 655.
4
KHA-CARI guideline: Early chronic kidney disease: detection, prevention and management.KHA-CARI指南：早期慢性肾脏病：检测、预防与管理
Nephrology (Carlton). 2013 May;18(5):340-50. doi: 10.1111/nep.12052.
5
An ongoing study of anemia correction in chronic kidney disease.一项正在进行的慢性肾脏病贫血纠正研究。
N Engl J Med. 2007 Mar 1;356(9):959-61. doi: 10.1056/NEJMc066568.
6
Iron replacement and supplementation in patients with chronic kidney disease.慢性肾脏病患者的铁替代与补充
CANNT J. 2011 Oct-Dec;21(4):26-30; quiz 31-2.
7
Anaemia: Does the KDIGO guideline move the needle in CKD anaemia?贫血：KDIGO指南对慢性肾脏病贫血有影响吗？
Nat Rev Nephrol. 2012 Nov;8(11):616-8. doi: 10.1038/nrneph.2012.218. Epub 2012 Sep 25.
8
KHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.KHA-CARI对KDIGO慢性肾脏病血脂管理临床实践指南的评论。
Nephrology (Carlton). 2014 Nov;19(11):663-6. doi: 10.1111/nep.12320.
9
Stabilizing hemoglobin levels: what's new in IV iron and anemia management?稳定血红蛋白水平：静脉铁剂与贫血管理有哪些新进展？
Nephrol Nurs J. 2008 Sep-Oct;35(5):493-502.
10
Darbepoetin alfa and chronic kidney disease.达比泊汀α与慢性肾脏病
N Engl J Med. 2010 Feb 18;362(7):654; author reply 655.

引用本文的文献

1
Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease Anemia.铁补充剂与缺氧诱导因子脯氨酰羟化酶结构域抑制剂联合用于治疗慢性肾脏病贫血
Kidney Dis (Basel). 2023 Aug 23;9(6):485-497. doi: 10.1159/000533304. eCollection 2023 Dec.
2
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.INFER-铁剂输注血液透析研究：血液透析高铁蛋白水平的原住民澳大利亚患者的静脉铁多聚糖治疗：一项前瞻性开放标签设盲终点随机对照试验方案。
Trials. 2021 Dec 2;22(1):868. doi: 10.1186/s13063-021-05854-w.
3
Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD.澳大利亚原住民和托雷斯海峡岛民慢性肾脏病患者高铁蛋白血症、缺铁及贫血管理挑战的叙述性综述
Kidney Int Rep. 2020 Nov 10;6(2):501-512. doi: 10.1016/j.ekir.2020.10.035. eCollection 2021 Feb.
4
Biomarkers of iron metabolism in chronic kidney disease.慢性肾脏病中铁代谢的生物标志物。
Int Urol Nephrol. 2021 May;53(5):935-944. doi: 10.1007/s11255-020-02663-z. Epub 2020 Oct 6.
5
Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.炎症对慢性肾脏病患者铁蛋白、hepcidin 及缺铁性贫血管理的影响。
Nutrients. 2018 Aug 27;10(9):1173. doi: 10.3390/nu10091173.
6
Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.慢性肾脏病患者贫血管理中铁剂治疗的实际考量
Clin Kidney J. 2017 Dec;10(Suppl 1):i9-i15. doi: 10.1093/ckj/sfx100. Epub 2017 Nov 28.
7
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.慢性炎症性疾病中的缺铁：关于定义、诊断和管理的国际专家意见
Am J Hematol. 2017 Oct;92(10):1068-1078. doi: 10.1002/ajh.24820. Epub 2017 Jul 7.
8
Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis.评估北领地接受维持性血液透析且血清铁蛋白水平较高的澳大利亚原住民患者的血清铁蛋白、转铁蛋白饱和度与C反应蛋白之间的关联。
Int J Nephrol. 2017;2017:5490963. doi: 10.1155/2017/5490963. Epub 2017 Jan 24.
9
Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial.静脉注射铁剂对血液透析患者成纤维细胞生长因子23（FGF23）的影响：一项随机对照试验。
BMC Nephrol. 2016 Nov 16;17(1):177. doi: 10.1186/s12882-016-0391-7.
10
Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis.静脉铁剂和促红细胞生成素刺激剂在血液透析中的应用：系统评价和荟萃分析。
Nephrology (Carlton). 2017 Dec;22(12):969-976. doi: 10.1111/nep.12940.